** = Publikationen gelistet in SCI/SSCI/Pubmed
** Barnard, KD; Wysocki, T; Ully, V; Mader, JK; Pieber, TR; Thabit, H; Tauschmann, M; Leelarathna, L; Hartnell, S; Acerini, CL; Wilinska, ME; Dellweg, S; Benesch, C; Arnolds, S; Holzer, M; Kojzar, H; Campbell, F; Yong, J; Pichierri, J; Hindmarsh, P; Heinemann, L; Evans, ML; Hovorka, R
Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy.
J Diabetes Sci Technol. 2017; 11(6):1080-1088
Doi: 10.1177/1932296817702656
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Emami, A; Willinska, ME; Thabit, H; Leelarathna, L; Hartnell, S; Dellweg, S; Benesch, C; Mader, JK; Holzer, M; Kojzar, H; Pieber, TR; Arnolds, S; Evans, ML; Hovorka, R
Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
Diabetes Technol Ther. 2017; 19(7):433-437
Doi: 10.1089/dia.2016.0307
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ruan, Y; Thabit, H; Leelarathna, L; Hartnell, S; Wilinska, ME; Tauschmann, M; Dellweg, S; Benesch, C; Mader, JK; Holzer, M; Kojzar, H; Evans, ML; Pieber, TR; Arnolds, S; Hovorka, R; AP@home consortium
Faster insulin action is associated with improved glycaemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetes.
Diabetes Obes Metab. 2017; 19(10):1485-1489
Doi: 10.1111/dom.12956
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Leelarathna, L; Thabit, H; Hartnell, S; Willinska, ME; Dellweg, S; Benesch, C; Mader, JK; Holzer, M; Kojzar, H; Evans, ML; Arnolds, S; Pieber, TR; Hovorka, R; AP@home Consortium
Rapid Benefits of Structured Optimization and Sensor-Augmented Insulin Pump Therapy in Adults With Type 1 Diabetes.
J Diabetes Sci Technol. 2017; 11(1):180-181
Doi: 10.1177/1932296816654715
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Leelarathna, L; Thabit, H; Willinska, ME; Dellweg, S; Mader, JK; Hartnell, S; Benesch, C; Holzer, M; Kojzar, H; Evans, ML; Arnolds, S; Pieber, TR; Hovorka, R; On behalf of AP@home consortium
Determining duration of closed-loop studies: evidence from a randomised day-and-night three month trial.
Diabetologia. 2017; 60(S1):S324-S325.-53rd Annual Meeting of the European Association for the Study of Diabetes; SEP 11-15, 2017; Lisbon, PORTUGAL.
[Poster]
Web of Science
** Ruan, Y; Thabit, H; Leelarathna, L; Hartnell, S; Willinska, ME; Dellweg, S; Benesch, C; Mader, JK; Holzer, M; Kojzar, H; Evans, ML; Pieber, TR; Arnolds, S; Hovorka, R; AP@home Consortium
Variability of Insulin Requirements Over 12 Weeks of Closed-Loop Insulin Delivery in Adults With Type 1 Diabetes.
Diabetes Care. 2016; 39(5):830-832
Doi: 10.2337/dc15-2623
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kojzar, H; Ruan, Y; Thabit, H; Leelarathna, L; Hartnell, S; Willinska, ME; Dellweg, S; Benesch, C; Mader, JK; Holzer, M; Evans, ML; Pieber, TR; Arnolds, S; Hovorka, R
Time to peak Insulin Action Duration influences the glycemic Outcome in Type 1 Diabetes during the Home Phase with Closed Loop Insulin Delivery
WIEN KLIN WOCHENSCHR. 2016; 128: S423-S423.
[Poster]
Web of Science
** Thabit, H; Tauschmann, M; Allen, JM; Leelarathna, L; Hartnell, S; Wilinska, ME; Acerini, CL; Dellweg, S; Benesch, C; Heinemann, L; Mader, JK; Holzer, M; Kojzar, H; Exall, J; Yong, J; Pichierri, J; Barnard, KD; Kollman, C; Cheng, P; Hindmarsh, PC; Campbell, FM; Arnolds, S; Pieber, TR; Evans, ML; Dunger, DB; Hovorka, R
Home Use of an Artificial Beta Cell in Type 1 Diabetes.
N Engl J Med. 2015; 373(22):2129-2140
Doi: 10.1056/NEJMoa1509351
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Holzer, M; Thabit, H; Leelarathna, L; Dellweg, S; Mader, JK; Hartnell, S; Benesch, C; Kojzar, H; Heinemann, L; Wilinska, M; Pieber, TR; Arnolds, S; Evans, M; Hovorka, R
12-wöchige Tag-und-Nacht Closed-Loop Insulinabgabe bei erwachsenen Typ 1 Diabetikern im Alltag: eine offene multizentrische multinationale prospektive randomisierte Crossover-Studie.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S145-S145.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Kojzar, H; Thabit, H; Leelarathna, L; Wilinska, ME; Elleri, D; Allen, JM, Lubina-Solomon, A; Walkinshaw, E; Stadler, M; Choudhary, P; Holzer, M; MAder, JK; Dellweg, S; Benesch, C; Pieber, TR; Arnolds, S; Heller, SR; Amiel, SA; Dunger, D; Evans, ML; Hovorka, R
Genauigkeit und Performance von kontinuierlichem Glukosemonitoring bei drei Closed-Loop-Studienmit Heimphase unter normalen Lebensbedingungen.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S145-S146.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Thabit, H; Leelarathna, L; Dellweg, S; Mader, JK; Hartnell, S; Benesch, C; Kojzar, H; Holzer, M; Heinemann, L; Wilinska, ME; Pieber, TR; Arnolds, S; Evans, ML; Hovorka, R; AP@Home consortium
Twelve-week unsupervised day-and-night closed loop insulin delivery during free daily living in adults with type 1 diabetes: a multicentre randomised cross-over study
DIABETOLOGIA. 2015; 58: S478-S478.-51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 14-18, 2015; Stockholm, SWEDEN.
[Poster]
Web of Science